European Uro-Oncology Group (EUOG) Navigation
  • Home
  • Clinical Trials
    • Open trial in metastatic Prostate Cancer I
    • Open trial in metastatic Prostate Cancer II
    • Open trial in MIBC
    • Open trial in URANUS
    • Open trial in Intravenous Liposomal dexamethasone
  • Meetings & Events
  • Join EUOG
  • Contact
  • EUOG in NL
  • About EUOG
    • EUOG Policy
    • EUOG Policy 2018-2023
    • EUOG Annual Report
  • Home
  • Clinical Trials
    • Open trial in metastatic Prostate Cancer I
    • Open trial in metastatic Prostate Cancer II
    • Open trial in MIBC
    • Open trial in URANUS
    • Open trial in Intravenous Liposomal dexamethasone
  • Meetings & Events
  • Join EUOG
  • Contact
  • EUOG in NL
  • About EUOG
    • EUOG Policy
    • EUOG Policy 2018-2023
    • EUOG Annual Report

Interviewer

3 November 2016

Matthew Smith

3 November 2016

Johann de Bono

3 November 2016

Bernard Escudier

3 November 2016

Per-Anders Abrahamsson

3 November 2016

Tim Eisen

3 November 2016

EUOG News

  • EUOG Newsletter June 2019 28 June 2019
  • Next EUOG meeting: March 17, 2019 30 January 2019
  • EUOG Newsletter December 2017 2 January 2018
  • ESMO September 2017: Bladder Cancer 2017 – KEYNOTE-045 trial 26 September 2017
  • ESMO September 2017: Results in study Nivolumab Plus Ipilimumab versus Sunitinib in First-Line Treatment for Advanced or Metastatic RCC 26 September 2017

Archives

  • June 2019
  • January 2019
  • January 2018
  • September 2017
  • August 2017
  • June 2017
  • March 2017
  • February 2017
  • October 2016